TipRanks
Go Ultimate55% OFF

Pacific Health Care Organization (PFHO) AI Stock Analysis

PFHO

Pacific Health Care Organization

(Other OTC:PFHO)

Select Model
Rating:77Outperform
Price Target:$1.00â–²(5.26% Upside)
Action:reiterated
Date:08/08/26

The overall score of 77 reflects a fundamentally strong company with a debt-free balance sheet and consistent cash flows, combined with an undervalued P/E ratio. Short-term technical indicators are mixed, with recent price strength but overbought signals, providing some caution. The primary strengths are the solid financial position and low valuation, while margin compression and technical resistance are secondary concerns.

Positive Factors
Conservative Balance SheetZero reported debt provides durable financial flexibility and lowers default risk, enabling the company to fund operations, invest in growth, or endure cyclical stress without interest burdens. This structural conservatism supports long-term resilience and strategic optionality.
Negative Factors
Margin CompressionMaterial decline from prior-year margins signals weaker pricing power, higher costs, or mix shifts that reduce operating leverage. If these pressures persist, they will structurally erode earnings convertibility of revenue, constrain reinvestment, and lower sustainable return on capital across coming quarters.

Pacific Health Care Organization (PFHO) vs. SPDR S&P 500 ETF (SPY)

-40%-30%-20%-10%0%10%20%PFHO-13.04%SPY+12.58%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$12.80M
Dividend Yield
―
Average Volume (3M)
10.05K
Price to Earnings (P/E)
13.1
Beta (1Y)
0.06
Revenue Growth
-2.60%
EPS Growth
-30.07%
Country
US
Employees
30
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Plans

Pacific Health Care Organization Business Overview & Revenue Model

Company Description

Pacific Health Care Organization, Inc. (PFHO), along with its various subsidiaries, specializes in providing targeted managed care services for workers' compensation throughout the United States. The company serves a wide array of clients, including...

How the Company Makes Money

null

Pacific Health Care Organization Financial Statement Overview

Summary

Strong balance sheet (score 90) with no debt and substantial equity, providing financial flexibility. Income statement (score 70) shows robust revenue growth but recent margin compression. Cash flow (score 75) is consistently positive with good coverage. Overall financial health is solid but tempered by margin pressures.

Income Statement

70Positive

Balance Sheet

90Very Positive

Cash Flow

75Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue6.44M6.72M6.07M5.63M5.74M5.40M
Gross Profit2.98M3.22M2.58M2.16M2.18M2.01M
EBITDA1.05M1.03M1.30M716.06K700.12K1.25M
Net Income978.75K1.39M883.58K767.93K492.89K995.02K
Balance Sheet
Total Assets14.11M13.48M12.43M11.82M12.05M11.33M
Cash, Cash Equivalents and Short-Term Investments12.47M12.21M11.10M10.44M10.78M10.09M
Total Debt0035.30K56.49K60.65K70.37K
Total Liabilities516.04K401.85K745.60K1.02M735.07K508.46K
Stockholders Equity13.60M13.07M11.69M10.80M11.32M10.82M
Cash Flow
Free Cash Flow569.93K1.14M665.95K914.84K672.37K368.01K
Operating Cash Flow597.74K1.16M675.08K932.36K711.24K386.39K
Investing Cash Flow-477.55K-990.15K-1.13M806.79K-8.76M-18.38K
Financing Cash Flow-36.38K-72.31K35.30K-1.21M0218.90K

Pacific Health Care Organization Technical Analysis

Technical Analysis SentimentPositive
Last Price0.95

Price Trends

50DMA0.98Positive
100DMA0.93Positive
200DMA1.05Negative

Market Momentum

MACD-0.00Negative
RSI57.17Neutral
STOCH49.21Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PFHO, the sentiment is Positive. The current price of 0.95 is below the 20-day moving average (MA) of 0.95, below the 50-day MA of 0.98, and below the 200-day MA of 1.05, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 57.17 is Neutral, neither overbought nor oversold. The STOCH value of 49.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PFHO.

Pacific Health Care Organization Risk Analysis

Pacific Health Care Organization disclosed 27 risk factors in its most recent earnings report. Pacific Health Care Organization reported the most risks in the "Production" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Production - Risks related to the company’s ability to manufacture goods and services

Latest Risks Added

1 New Risk
1.Management does not believe there have been any material changes to the risk factors listed under Part I, Item 1A Risk Factors of our Annual Report.Q2, 2026

Pacific Health Care Organization Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

PFHO against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
PFHOPFHO77Outperform$12.16M13.077.42%―-2.60%-30.07%
CLOVCLOV73Outperform$2.37B-106.42-5.38%―54.04%57.31%
OSCROSCR70Outperform$9.38B18.1338.53%―42.82%―
CNCCNC64Neutral$33.89B22.486.78%―9.71%―
ALHCALHC59Neutral$1.52B49.7212.46%―35.87%―
MOHMOH52Neutral$10.69B-341.72-1.17%―-0.95%-105.84%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

-50%0%50%100%PFHOCNCMOHCLOVOSCRALHCDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
PFHO and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
PFHOPacific Health Care Organization, Inc.1.00-0.15-13.04%
CNCCentene66.5330.4284.24%
MOHMolina Healthcare Inc208.4556.7637.42%
CLOVClover Health Investments Corp4.310.7922.44%
OSCROscar Health, Inc.31.0013.8480.65%
ALHCAlignment Healthcare, Inc.7.00-10.09-59.04%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 08, 2026